Pricing Log in Create free account

Cogent Biosciences, Inc. (COGT) vs Scholar Rock Holding Corporation (SRRK)

Cogent Biosciences, Inc. and Scholar Rock Holding Corporation are both Biotechnology companies. Cogent Biosciences, Inc. and Scholar Rock Holding Corporation are of similar size ($5.1B and $5.0B). Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against 110.2%. Across the 12 metrics below, Cogent Biosciences, Inc. leads on 7 and Scholar Rock Holding Corporation on 5.

Valuation

Metric COGT SRRK Biotechnology median
P/E n/m n/m 8.50
P/S 217.97 110.04 9.71
P/B 10.79 20.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 193.41 103.78 9.21
Earnings yield (7.32%) (8.66%) (33.15%)
Free cash flow yield (6.13%) (5.71%) (25.50%)

Profitability

Metric COGT SRRK Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (146.55%) (167.77%) (56.36%)
Return on assets (68.00%) (94.63%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COGT SRRK Biotechnology median
Revenue growth (TTM) 110.23% 213.65% 6.02%
EPS growth (last fiscal year) (11.34%) (33.20%) 30.26%
Revenue growth, 5-year CAGR 21.39% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COGT SRRK Biotechnology median
Debt to equity 0.42 0.77 0.00
Current ratio 13.57 7.02 4.72
Net debt to EBITDA 2.04 0.69 0.96

Dividend

Metric COGT SRRK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COGT SRRK Biotechnology median
Market cap 5.12b 4.95b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack